<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05111106</url>
  </required_header>
  <id_info>
    <org_study_id>AEJO-2018-Symfony</org_study_id>
    <nct_id>NCT05111106</nct_id>
  </id_info>
  <brief_title>Symfony Intraocular Lens Retrospective Chart Review</brief_title>
  <official_title>Experience With Symfony Extended Depth of Focus (EDOF) IOL: A Retrospective Chart Review</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Austin Eye</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johnson &amp; Johnson</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Austin Eye</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective chart review of patients with pre-existing ocular pathology who underwent&#xD;
      cataract surgery with implantation of the Symfony IOL.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This was a retrospective chart review conducted at a single US clinical site. Chart review&#xD;
      was conducted by John Odette, MD and research assistants. Eligible charts were identified via&#xD;
      a clinic database search of cataract surgeries with IOL implantation of the Symfony IOL&#xD;
      during the stated date range. Eligible charts included those of patients 18 to 90 years of&#xD;
      age who underwent Femto Laser Assisted Cataract Surgery (FLACS) with implantation of a&#xD;
      Symfony IOL. Charts were excluded for lack of postoperative follow-up or if Symfony IOL was&#xD;
      not implanted. All qualifying patient charts were examined and further classified into 2&#xD;
      groups: (1) eyes with glaucoma; and 2) eyes without glaucoma. Visual acuity was evaluated for&#xD;
      patients who underwent cataract surgery with implantation of the Symfony IOL from 09/1/2016&#xD;
      to 05/31/2018. Postoperative evaluations at Month 2 included mean monocular uncorrected&#xD;
      visual acuity at near (UNVA) at 40 cm, far distance (UDVA) at 20 ft, and with best correction&#xD;
      (CDVA). Outcomes were also compared for toric IOLs versus spherical IOL.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 5, 2016</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Monocular uncorrected near visual acuity</measure>
    <time_frame>2 months</time_frame>
    <description>handheld near card (Jaeger scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Monocular best corrected distance visual acuity</measure>
    <time_frame>2 months</time_frame>
    <description>Snellen Chart at 20 feet</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">463</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Non-Pathology Eyes</arm_group_label>
    <description>Cataract Surgery with implantation of Symfony IOL in eyes without pre-existing pathology..</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glaucoma Eyes</arm_group_label>
    <description>Cataract Surgery with implantation of Symfony IOL with pre-existing glaucoma.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retinopathy Eyes</arm_group_label>
    <description>Cataract Surgery with implantation of Symfony IOL in eyes with pre-existing retinal pathology..</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Symfony IOL</intervention_name>
    <description>Implantation of Intraocular lens with extended depth of focus.</description>
    <arm_group_label>Glaucoma Eyes</arm_group_label>
    <arm_group_label>Non-Pathology Eyes</arm_group_label>
    <arm_group_label>Retinopathy Eyes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients (18-90 years old) in need of cataract surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  :Phacoemulsification cataract surgery with a Symfony IOL.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  : Eyes not implanted with a Symfony IOL or unstable refractive results at final&#xD;
             post-operative visit&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Odette</last_name>
    <role>Principal Investigator</role>
    <affiliation>Austin Eye Center</affiliation>
  </overall_official>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 27, 2021</study_first_submitted>
  <study_first_submitted_qc>October 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Austin Eye</investigator_affiliation>
    <investigator_full_name>John Odette</investigator_full_name>
    <investigator_title>John Odette, MD</investigator_title>
  </responsible_party>
  <keyword>Cataract surgery</keyword>
  <keyword>Glaucoma</keyword>
  <keyword>Retinopathy</keyword>
  <keyword>Intraocular Lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

